AC
CVS icon

Armistice Capital’s CVS Health CVS Stock Holding History

Armistice Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-295,589
Closed -$23.5M – 316
2025
Q4 		$23.5M Buy
295,589
+3,770
+1% +$297K 0.28% 59
2025
Q3 		$22M Buy
+291,819
New +$20M 0.33% 47
2023
Q2 		– Sell
-156,000
Closed -$11.6M – 234
2023
Q1 		$11.6M Sell
156,000
-320,000
-67% -$26.8M 0.17% 86
2022
Q4 		$44.4M Buy
+476,000
New +$45.9M 0.77% 30
2022
Q1 		– Sell
-192,000
Closed -$19.8M – 153
2021
Q4 		$19.8M Buy
+192,000
New +$17.7M 0.32% 71
2020
Q4 		– Sell
-500,000
Closed -$29.2M – 111
2020
Q3 		$29.2M Buy
500,000
+328,000
+191% +$20.4M 1.06% 35
2020
Q2 		$11.2M Sell
172,000
-206,000
-54% -$13M 0.49% 59
2020
Q1 		$22.4M Buy
+378,000
New +$25.2M 1.39% 27
2019
Q1 		– Sell
-158,000
Closed -$9.75M – 75
2018
Q4 		$10.4M Buy
158,000
+58,000
+58% +$4.33M 0.78% 29
2018
Q3 		$7.87M Sell
100,000
-400,000
-80% -$28.6M 0.47% 49
2018
Q2 		$32.2M Buy
500,000
+8,000
+2% +$527K 2.1% 15
2018
Q1 		$30.6M Buy
492,000
+292,000
+146% +$21M 2.34% 14
2017
Q4 		$14.5M Buy
+200,000
New +$14.5M 1.45% 25

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Armistice Capital's CVS Position: Q1 2026 in Review

Armistice Capital sold out of CVS Health (CVS) in Q1 2026, closing a stake of 295,589 shares — an estimated $23.5M sold.

Armistice Capital first reported a position in CVS in Q4 2017 and held it in 13 quarters. The position peaked at $44.4M in Q4 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Armistice Capital reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Armistice Capital sold 295,589 CVS Health shares in Q1 2026, an estimated $23.5M.
  • Armistice Capital first reported a position in CVS Health in Q4 2017 and held it in 13 quarters.
  • Armistice Capital's CVS Health position peaked at $44.4M in Q4 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.